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Abstract
Considered for decades as a cartilage disease, recent studies of osteoarthritis (OA) take us back to the concepts 
discussed at the naming of the disorder as “bone-joint-inflammation”. By describing the joint as an organ, can 
OA be called an organ disease – similar to heart disease? Is there a systemic (which system?) involvement? 
Would this help with diagnosis or therapy? Hyperplasia of the joint tissues is one of the most notable early 
features of the disease: articular cartilage thickens, chondrocytes proliferate and increase matrix biosynthesis, 
but not its incorporation; the subchondral bone densifies but is hypomineralised and there is an increase 
in bone marrow fat content. Associations between OA and hypertension, hypercholesterolaemia and blood 
glucose suggest systemic and metabolic components are involved. The source of pain is still unknown but 
there is evidence for peripheral and central sensitisation. Joint deformity is difficult to quantify, but statistical 
shape modelling provides a tool to use as an imaging biomarker. A genome-wide association study meta-
analysis has identified novel genes associated with hip shape with many genes related to tissue growth and 
development. There are associations between hip shapes and age of first walking as well as with obesity 
through adulthood. These life-course events and a recapitulation in old age of developmental processes 
suggest that the cradle may affect our path to the grave. These observations suggest that tissue regeneration 
approaches, treating only the cartilage in OA joints, may only be of limited benefit.
Keywords: Osteoarthritis, joint, systemic disease, metabolic disease, aetiology, growth, hyperplasia, 
development.
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Introduction
Osteoarthritis (OA) has been considered for many 
decades as a disorder of articular cartilage arising 
from “wear and tear”. However, recent studies appear 
to be taking us back to the concepts considered at the 
naming of the disorder as osteo-arthr(o)-itis; “bone-
joint-inflammation”. The recent review by Dobson 
and colleagues on the naming of “osteoarthritis” 
(Dobson et al., 2018) attributes the name to surgeon 
Richard von Volkmann in the mid-nineteenth century 
to distinguish the disorder from rheumatoid arthritis 
(RA) and gout. Others suggest that Garrod originated 
the term in 1890 and he certainly popularised it in 
the 1907 edition of Albutt and Rolleston’s System 
of Medicine in which he describes separately these 
disorders (Garrod, 1907). Garrod was also a surgeon 
and his observations of the joint in the operating 
theatre led him to support the idea of a whole 
joint disorder associated with inflammation and, 
interestingly, he also suggested that the central 
nervous system played a key role. Cartilage was, 
seemingly, not considered to be important. By the 
1950s, with the advent of more sophisticated methods 
for biochemical analysis and, later, molecular biology, 
cartilage became the dominant tissue of interest and 
very little was made of the subchondral bone or other 
joint tissues. Although there are some papers from 
over 25 years ago advocating that OA is whole joint 
disease the idea had not gained much traction until 
recently when there has been a shift in thinking in 
the osteoarthritis research community. There has 
been a refocusing from solely cartilage-based studies 
to contemplating the whole joint and the associated 
tissues as a whole-joint disorder and considering 
the interactions between the soft tissues and the 
mineralised tissues. This is reflected in the increased 
number of papers including soft tissues in their 
studies, thus returning full circle to ideas laid out by 
Garrod over a hundred years ago. Whilst the number 
RM Aspden & FR Saunders                                                                                     Osteoarthritis as an organ disease
75 www.ecmjournal.org
of papers focusing on cartilage has not decreased, 
there is an increased number of papers that deal with 
other aspects of osteoarthritis pathology, including 
soft tissue interactions with cartilage and mineralised 
tissue.
 Some forms of OA follow trauma and affect a 
single joint, an abnormal load on a normal joint. Most, 
however, are still classed as idiopathic – unknown 
cause – and are polyarticular in nature. Traditionally, 
idiopathic OA has been suggested to arise from 
normal loads on abnormal cartilage or from abnormal 
loads on normal cartilage. In both of these scenarios, 
the abnormality is often much more elusive than an 
obvious traumatic incident. Curiously, hand OA is 
one of the most prevalent forms of OA, affecting 
around 35% of adults (Haugen et al., 2011) and hands 
are rarely subject to abnormal loads, suggesting some 
other cause. Despite the history of the name described 
above, the emphasis in recent decades has largely 
been on the articular cartilage of the synovial joints 
as the affected tissue and biomechanical factors as 
the causative agents. Changes in other tissues have 
been treated as secondary, including alterations 
to subchondral bone and other tissues believed to 
arise from secondary inflammation and enforced 
inactivity.
 In some recent publications, it is proposed that 
the joint should be considered as an organ (Loeser 
et al., 2012; Lories and Luyten, 2010; Radin et al., 
1991). Can OA, therefore, be described as an organ 
disease in a similar way to heart disease? Is there a 
systemic involvement and, if so, by which system or 
systems? Does this help with diagnosis or therapy? 
Indeed, does this view complicate the treatment of 
OA? In this review the effects of OA on a number of 
joint tissues were examined and an attempt made 
to show that, although “cartilage first” cannot be 
ruled out, it is not the only, – or even necessarily the 
best – explanation for the hyperplasia observed in 
many tissues forming the joint. Similarly, although 
biomechanics almost certainly plays an important 
role in the progression of the disease, its part in the 
incidence of primary generalised OA is less clear. It 
may be the factor that determines, in any individual, 
which joint displays the first signs; however, the 
working hypothesis was that generalised OA is 
a recapitulation or renewing of growth processes 
that should have ceased permanently at the end of 
development and that these are driven by metabolic 
and systemic factors.
 It is proposed that OA, at least in its generalised 
form, is a systemic musculoskeletal disease, further 
developing ideas presented previously (Aspden, 
2008; Aspden, 2011; Aspden et al., 2001). Specifically, it 
is suggested that OA is characterised by dysregulated 
growth of musculoskeletal tissues and that many 
of the cells appear to have reverted to an earlier 
developmental phenotype. The outcome is new 
tissue being formed in the wrong place and at the 
wrong time, matrix components not being properly 
incorporated and a resulting loss of the mechanical 
properties required for normal function. Initially a 
discussion of articular cartilage is presented, as this 
is largely the focus of tissue repair strategies, before 
considering some of the other tissues comprising the 
joint.
Articular cartilage
Cartilage loss is one of the most obvious radiographic 
signs, often described as “joint space narrowing”. On 
a radiograph the bone is opaque and the cartilage is 
transparent. If this remarkably smooth load-bearing 
surface is lost, joint function will be compromised as 
the bones are forced closer together and ultimately 
touch – rubbing together. Several significant 
structural changes result, such as the loss of the low 
friction environment, increased sensations of pain 
as innervated bones rub together and, therefore, 
changes in the bone and functional impairment. The 
loss of cartilage, however, is a late event that occurs 
after more subtle structural and molecular changes 
in both the bone and the articular surfaces and is 
accompanied by a chronic, low-grade inflammation. 
This is in direct contrast to the pathophysiology of RA 
where the primary initiating factor is inflammatory 
in nature and the changes in cartilage and bone are 
secondary (Thysen et al., 2015).
 The role of the chondrocyte in articular cartilage 
is extensively reviewed (Goldring, 2000b; Goldring 
and Goldring, 2007). Essential features of the process 
often described as degeneration are tissue swelling, 
cell proliferation, fibrillation and finally erosion. 
The first observable sign is swelling of the tissue as 
it absorbs more water (Maroudas, 1976; Wang et al., 
2008). This is accompanied by renewed cell division 
(Mankin et al., 1981), or cloning, of the chondrocytes 
within their chondron, producing multiple cells 
where in normal tissue there are typically only 
2-4 chondrocytes (Mankin et al., 1981; Poole, 
1997). Synthesis of the principal matrix molecules 
increases (Goldring and Goldring, 2007), including 
collagen type II (Aigner et al., 1997) and aggrecan 
(Roughley and Mort, 2014). In the very early stages 
of the disease, when only minor surface fibrillation 
is apparent, there is substantial release of aggrecan 
fragments. However, the net tissue concentration of 
aggrecan does not decrease (reviewed by Heinegard 
and Saxne, 2011), indicating that much of this new 
material appears to be lost rapidly to the joint cavity. 
Hence, one of the markers for increased tissue 
turnover is elevated levels of aggrecan fragments in 
the synovial fluid (Lohmander et al., 1999; Roughley 
and Mort, 2014). There are also reports of substantial 
increases in the abundance of cartilage oligomeric 
protein (COMP) and cartilage intermediate layer 
protein CILP-1. These new accumulations occur 
close to the chondrocytes (Lorenzo et al., 2004). 
It is reported that the altered distributions of 
these two proteins present a typical and distinct 
hallmark of the cartilage in the early osteoarthritic 
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process. This is the result of molecules being lost 
from one compartment, through degradation, and 
accumulating in another as a result of new synthesis 
(Heinegard and Saxne, 2011). It is also reported 
that this distinctive distribution is similar to that 
found during embryonic development (Heinegard 
and Saxne, 2011; Shen et al., 1995). Interestingly, the 
expression of collagen type II changes from type IIB, 
the adult form, to type IIA – a splice-variant that is 
normally expressed during development (Aigner et 
al., 1999). Work from Bruce Caterson’s lab shows that 
there are specific epitopes of chondroitin sulphate 
(4-C-3, 7-D-4 and 3-B-3(-)), more commonly found in 
foetal tissue, decorating the cell surface proteoglycans 
on activated stem cells. This could be a signal that 
these cells are a target for tissue development (Hayes 
et al., 2018). The significance of these specific epitopes 
is that they are commonly found on progenitor cells, 
which occur in increased numbers in OA tissue. This 
provides further evidence of a reversion to a more 
developmental-like phenotype. Increased matrix 
synthesis is accompanied by increased biosynthesis 
of matrix metalloproteases (MMPs), prostaglandins 
and other inflammatory factors. These may arise from 
elevated levels of interleukin IL-1 and tumour necrosis 
factor TNFα (Goldring, 2000a; Goldring, 2000b; Zhuo 
et al., 2012). An increase in the pro-inflammatory 
precursor arachidonic acid, and other lipids, is also 
reported to be associated with histological severity 
of OA (Lippiello et al., 1991). Finally, the tidemark 
– which marks the junction between calcified and 
uncalcified cartilage – is duplicated and advances 
into the previously uncalcified tissue (Oettmeier et 
al., 1989; Radin et al., 1991). This is another indicator 
of renewed growth and tissue formation, though 
the underlying mechanisms are still unknown. A 
stereological study reports an increase in the area 
covered by the tidemark, with a greater number of 
blood vessels crossing it, that is taken to be indicative 
of a vascular involvement in the pathology (Bonde 
et al., 2005). This feature is quite difficult to model in 
animals due to the differences in OA pathology of 
cartilage structure, particularly in rodents. However, 
there is an in vitro co-culture model of osteoblasts and 
chondrocytes that can be used to model the changes 
in the tidemark (reviewed by Thysen et al., 2015) and 
a model in dogs (Daubs et al., 2006).
 Articular cartilage may be considered as a 
biological fibre-composite material in which collagen 
fibrils provide tensile reinforcing to a highly hydrated 
proteoglycan gel (Aspden, 1994). Viewed in this 
way, it is the interactions between collagen and the 
other components that provide mechanical integrity 
(Aspden, 1994; Burgin et al., 2014; Hukins et al., 
1984; Lewis et al., 1998) – not simply a stiff collagen 
‘network’ and a filler. The organisation of the fibrils 
(Aspden and Hukins, 1981; Jeffrey and Aspden, 2006), 
the electrostatic properties of the gel (Dean et al., 2003; 
Seog et al., 2002) and interactions between the fibrils 
and the gel (Aspden, 1994; Rojas et al., 2014) are tightly 
regulated during development and in response 
to a changing loading environment to produce 
appropriate mechanical properties. Proteoglycan 
turnover, but not collagen turnover (Heinemeier et 
al., 2016), then maintains the mechanical stability of 
the tissue. The carbon-14 bomb dating method used 
by Heinemeier et al. (2016) demonstrates the relative 
stability of the collagen structure in both healthy 
and diseased tissue. Page Thomas and colleagues 
demonstrate, in rabbits, that – after an immediate 
extensive loss of proteoglycans from cartilage – there 
is suppression of the production in the immediate 
aftermath of injury but this then doubles its rate after 
one week (Page Thomas et al., 1991). Excess synthesis 
of new matrix and a reversion of the chondrocytes to 
a developmental-like phenotype could weaken the 
tissue by inappropriate remodelling. Weakening of 
the tissue in this way could then make it susceptible 
to mechanical damage. Even in elderly tissue, 
chondrocytes respond to mechanical (Plumb and 
Aspden, 2005) and chemokine stimuli (Plumb et 
al., 2006) and to tissue damage (Jeffrey et al., 1997). 
However, once the tissue structure, especially the 
collagen organisation, has been lost it does not 
presently seem possible to restore it. Catterall and 
colleagues show that the half-life of collagen is very 
long, in excess of 100 years; therefore, the loss of 
collagen appears to be irreversible (Catterall et al., 
2016). Studies of mechanical loading, on elderly 
human articular cartilage, indicates that both cyclic 
and static loads inhibit matrix macromolecule 
biosynthesis (Plumb and Aspden, 2005) and could 
over-ride the normally stimulatory effect of IGF-1 
(Plumb et al., 2006; Wheeler et al., 2009). This differs 
from results from young bovine tissue where cyclic 
load is generally found to be stimulatory (Guilak et 
al., 1994; Larsson et al., 1991; Palmoski and Brandt, 
1984; Sah et al., 1989). Supporting this, preliminary 
gene expression studies comparing OA cartilage with 
that obtained from hip fracture patients indicated 
that cyclic loading produced no changes in gene 
expression for matrix macromolecules at greater 
than a 4-fold level but that there were changes in the 
expression of growth factors (FGF-18, FGF-2, VEGF 
and WNT16), all of which promote chondrocyte 
division, and molecules associated with increased 
matrix turnover such as COX-2 and ADAMTS-1 
(Meeting abstract: Plumb and Aspden. Osteoarthritis 
Cartilage 2005 13: S104.).
Bone
A number of signs of OA appear in the bones forming 
the joint. These include sclerosis of the subchondral 
bone, the formation of so-called “cysts” in the 
trabecular bone, and osteophytosis. Cysts are cavities 
in the cancellous bone, often found in late-stage OA 
below the loaded articulating region (Havdrup et 
al., 1976). The mechanism of cyst formation is still 
unclear. Recent studies favour the idea of bone 
contusion over synovial fluid intrusion, due to their 
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association with bone marrow lesions seen using 
magnetic resonance imaging (MRI) (Carrino et al., 
2006; Crema et al., 2010). Irrespective of how they 
are initiated, removal of so much bone suggests 
significantly increased osteoclastic activity (Havdrup 
et al., 1976). In contrast, osteophytes are outgrowths 
of bone and cartilage found in many patients at the 
margins of diarthrodial joints or as outgrowths in the 
central portions of the articular space in about 15% 
of patients (McCauley et al., 2001), as well as in the 
spine, around zygoapophyseal joints and vertebral 
bodies particularly in the lumbar region (Klaassen 
et al., 2011). Osteophytes form by endochondral 
ossification (Gelse et al., 2003). The latter process 
shows many similarities to bone formation during 
development and the signalling pathways activated 
during osteophyte formation are shown to be 
similar to those found in callus formation during 
fracture repair (Arden and Nevitt, 2006; Patel et al., 
2003; van der Kraan and van den Berg, 2007). Bone 
usually adapts in response to mechanical loading 
and growth of new tissue, in the absence of such 
a stimulus, requires other causes. One suggestion 
is that TGF-β could provide this signal (Scharstuhl 
et al., 2002; van Beuningen et al., 1994). Similarly, 
subchondral sclerosis has traditionally been regarded 
as a reaction to increased load following cartilage 
loss. Several studies, however, indicate that bone 
changes are evident concurrently with cartilage 
fibrillation (Dedrick et al., 1993) or that sclerosis is 
evident radiographically before joint space narrowing 
(Buckland-Wright et al., 1995).
 Patients with radiographic OA of the hip are 
reported to have an elevated bone mineral density not 
only in the hip but also in the distal radius, vertebrae 
and calcaneus (Nevitt et al., 1995). Scintigraphy, 
using technetium 99m, shows increased bone 
forming activity in joints with pathological signs 
of OA (Buckland-Wright et al., 1995). Laboratory 
studies show alterations in the bone matrix and 
in osteoblast behaviour. In the hip, an increase in 
cancellous bone volume of about 60% was found but 
this was associated with a reduced mineralisation 
(Li and Aspden, 1997a). Using back-scattered as 
well as secondary emission electron microscopy, the 
appearance of the cancellous bone was found to be 
similar to woven bone seen in fracture repair (Li et 
al., 1999) with evidence of osteoclastic resorption in 
the form of Howship lacunae. In addition, although 
the subchondral bone plate was thicker, it too was 
less well mineralised (Li and Aspden, 1997b) (Fig. 
1). Increased amounts of bone are reported in the 
iliac crest of patients with OA of the hand (Gevers 
et al., 1989a; Gevers et al., 1989b), together with 
greater levels of growth factors (Dequeker et al., 
1997) – supporting the concept that OA may be a 
part of a generalised disorder. Among the anabolic 
factors identified as important in bone formation 
Fig. 1. Scanning electron micrograph of subchondral bone from a 75-year-old patient following 
total hip replacement for OA. The porous and coarse texture of the bone matrix is apparent, and 
measurement showed the matrix to be hypomineralised.
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are the Wnt family and several studies show their 
differential regulation in OA (Burr and Utreja, 2018; 
Corr, 2008; Luyten et al., 2009). In a preliminary 
gene expression study, not only was differential 
regulation of some of the more obvious members 
of Wnt signalling pathways found but that the most 
differentially regulated gene was that for NHERF1 
(Sodium/hydrogen exchange regulatory cofactor 
1; SLC9A3R1) that was strongly down-regulated 
(Hochet and Aspden, 2007). NHERF-1 acts with 
NHE-3 (sodium/hydrogen exchanger 3, SLC9A3) to 
regulate intracellular pH through control of sodium 
and potassium ion concentrations but is also shown 
to interact with PTEN (phosphatase and tensin 
homologue), a tumour suppressor, and to regulate 
cell proliferation in various cancers and cell types 
(Li et al., 2015; Molina et al., 2012; Takahashi et al., 
2006). Immunofluorochemistry studies demonstrate 
cytoplasmic accumulation of NHERF-1, PTEN and 
β-catenin, consistent with increased AKT (also known 
as protein kinase B) activation and Wnt signalling 
due to the translocation of the β-catenin that has 
accumulated in the cytoplasm to the nucleus in both 
chondrocytes and osteoblasts from OA femoral heads 
(Griffin-Walker et al., 2017; White et al., 2015). A 
similar translocation was found from cell membrane 
to the cytoplasm for NHERF-1 to that which is 
reported in tumour growth, supporting its possible 
role in hyperplasia (Griffin-Walker et al., 2017).
Obesity and adipose tissue
There is a recognised association between being 
overweight and OA of knees, hips and hands (Issa 
and Griffin, 2012; Reyes et al., 2016; Thijssen et al., 
2014). Is this mechanical or metabolic, or both? Being 
overweight is known to predate the incidence of 
disease (Felson et al., 2000). Results from both the 
Chingford and the Framingham studies show that 
body mass index (BMI) is linked to all patterns of 
knee OA (Cooper et al., 1996; Felson et al., 1988; Hart 
et al., 1995). Mechanical overloading is the obvious 
mechanism for subsequent cartilage degeneration. 
This may play a role in knee and hip OA but much 
harder to understand in OA of the hand, where 
baseline obesity is associated with the incidence 
of hand OA 23 years later (Carman et al., 1994). A 
growing literature is increasingly pointing away from 
a simple link between mechanical overloading and 
OA. Or, conversely, that obesity is a consequence of 
reduced activity due to joint pain. The role of adipose 
tissue as an endocrine organ secreting adipokines is 
increasingly prevalent (Aspden, 2011; Berenbaum 
and Sellam, 2008; Francisco et al., 2018; Issa and 
Griffin, 2012; Pottie et al., 2006; Reyes et al., 2016; 
Thijssen et al., 2014). The association between OA 
and being overweight is strongest with incidence 
and severity but not with progression. This is shown 
clearly in a study that recruited morbidly obese 
women (body mass index (BMI) between 30 and 50 
kg/m2), on the basis that they would progress fastest 
and enable a therapeutic approach to be tested most 
rapidly (Hellio Le Graverand et al., 2009). Joint space 
narrowing does not increase with BMI and they 
conclude that there is nothing to be gained from 
using this measure by recruiting obese individuals.
 Following observations that femoral heads 
recovered from OA patients, after total hip 
replacements, seem to contain much more fat than 
those from osteoporotic patients, the fat content and 
the fatty acid composition was measured (Plumb 
and Aspden, 2004). It was found that the bone cores 
from OA bone contained twice the mass of fat per 
unit volume of tissue as osteoporotic bone. The fat 
contained more (n-6) fatty acids, and the amount 
of arachidonic acid was double that found in the 
tissue from osteoporotic bone. These fatty acids are 
the substrates for the cyclo-oxygenase enzymes, 
that are the target of many non-steroidal anti-
inflammatory drugs, and result in the formation 
of prostaglandins – active pro-inflammatory 
mediators. Features of OA are suggested to have 
many similarities with atheromatous vascular 
disease (Marks and Allegrante, 2002) and the role 
of lipids in calcification is an active area of study in 
the formation of atherosclerotic plaques (Parhami 
et al., 2001), as well as the differentiation of stem 
cells into osteoblasts and adipocytes (Parhami et 
al., 1999). These systemic and metabolic markers 
indicate that OA may, therefore, be a part of the so-
called Metabolic Syndrome (MetS). MetS has a very 
broad spectrum of included syndromes/diseases 
and includes obesity, hypercholesterolaemia, 
hyperlipidaemia, hypertension and cardiovascular 
disease as characterised by atherosclerotic plaques 
(Zhuo et al., 2012). However, a recent systematic 
review of the link between MetS and OA in different 
joints, by Li and Felson, indicates that there is no 
relationship with hip OA. The possible associations 
with hand and knee OA are not clear, due to 
limitations in the studies. These are reported to be 
small in participant numbers, mainly cross-sectional 
in nature with few outcome measures or adjustment 
for co-variates (Li and Felson, 2018). There is a 
growing understanding that cells of mesenchymal 
origin can not only be directed to differentiate down 
specific lineages, by soluble factors activating the 
relevant nuclear receptor, but also may be redirected 
by modulating the nature of their stem-cell niche. 
Hence, modulating the stem-cell precursors may 
affect all the cell lineages derived from those stem 
cells and, consequently, affect the composition and, 
therefore, the functionality of all the derived tissues. 
This knowledge begins to open new avenues for 
understanding why so many tissues are affected 
by the disease process and, perhaps, why adipose 
tissue is one of the key drivers of OA (Aspden, 
2011). Genetic and epigenetic factors are shown to 
be transmitted through cell lineages. For example, 
re-expression of growth and development factor 5 
(Gdf-5), is found in the synovium of mouse models 
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of OA, with a role in cartilage repair. Also, a second 
gene, one of the bone morphogenetic factors Bmp-7, 
is shown to play a critical role in joint patterning 
(Roelofs et al., 2017).
Synovial hyperplasia
One aspect of osteoarthritis development which 
has received a significant amount of interest is 
synovial hyperplasia. A review by de Lange-Brokaar 
and colleagues uncovers 100 different papers that 
show different aspects of synovial hyperplasia in 
humans (de Lange-Brokaar et al., 2012). This includes 
investigations of synovial tissue proliferation, 
infiltration of the tissue by macrophages and – to a 
lesser extent – neutrophils, quantification of cytokines 
such as IL-1β and IL-6, the role of other immune 
cells such as T-cells and the degree of inflammation 
that is involved. A PubMed search using the terms 
“synovial hyperplasia” and “osteoarthritis” showed 
that there were over 200 papers on this particular 
topic, indicating the complexity of the synovial tissue 
and its role in OA pathophysiology. It is commonly 
believed that there is no inflammatory involvement 
in the development of OA. However, this view 
seems to have shifted to show that there are indeed 
low levels of inflammation present in many patients 
with OA, albeit at a lower level than is commonly 
associated with RA (Sokolove and Lepus, 2013). There 
are reports of increased levels of the cytokines IL-1β 
and TNF-α (tumour necrosis factor alpha) in cartilage 
matrices undergoing degeneration (Kapoor et al., 
2010). Many papers highlight that in OA tissue there 
are increased features of hyperplasia, demonstrated 
by increased scores compared with normal tissue. 
The seminal work of Mankin, in developing a robust 
scoring system for the classification of hyperplasia 
and associated changes observed in OA (Mankin 
et al., 1981), cannot be overlooked and has been 
key in changing the mindset that the condition of 
the cartilage is the most critical pathophysiological 
change in OA development. This is reflected in the 
subsequent updates to the consensus OARSI scoring 
system (Pritzker et al., 2006).
Other indicators of growth
The joint capsule is a tough, strong tissue that not 
only contains the joint fluid but also plays a vital, and 
commonly under-estimated, role in the biomechanics 
of synovial joints. Capsular ligaments augment 
other ligaments to maintain joint stability (Ralphs 
and Benjamin, 1994). In OA there is progressive 
fibrosis of the capsule and of the ligaments, resulting 
in thickening and shortening of the tissue and a 
reduction in its flexibility (Lloyd-Roberts, 1953). 
Ruptures of the anterior cruciate ligament are found 
to be far more common in subjects with symptomatic 
knee OA (Hill et al., 2005). In patients, a history of knee 
injury is associated with increased radiographic OA 
(Johnson and Hunter, 2014). Although such an injury 
is a known risk factor for secondary OA, it cannot 
be determined which came first. However, there is 
evidence from the Osteoarthritis Initiative that loss 
of ACL integrity and the development of incident 
radiographic OA are not related (Johnson et al., 2015). 
It is possible, in some patients, that ligament damage 
arose after the onset of disease as a consequence of 
altered tissue biomechanical properties. Studies of 
OA in the STR/ort mouse show that cruciate ligament 
metabolism is upregulated before radiological signs 
are present and that the tissue is weaker than in 
controls (Anderson-MacKenzie et al., 1999; Staines 
et al., 2017).
 The changes in quantity, appearance and viscosity 
of synovial fluid in OA are well documented but 
high numbers of mesenchymal precursor cells 
(mesenchymal stem cells (MSCs)) are reported in 
synovial fluid from OA patients (Jones et al., 2004). 
Because levels are higher than in RA, it is suggested 
that these are not simply a consequence of an 
inflammatory process. These cells are pluripotent, 
with their ultimate phenotype able to be manipulated 
by altering the chemical composition of the culture 
medium. They possess the ability to be differentiated 
in culture to three main cell types; osteoblasts, 
chondrocytes and adipocytes. The origin of the MSCs 
is currently unknown, but cells with stem-cell-like 
properties are being identified in most joint tissues 
(Franceschetti and De Bari, 2017). Multiplication of 
stem cells could have a key role in the underlying 
tissue hyperplasia being described here as well as 
in the return to a more developmental phenotype 
but their presence, and in what numbers, is still an 
active area of investigation. By better understanding 
the origin of these cells and the factors required to 
drive them to differentiate into specific cell lineages, 
a deeper explanation of why cells in OA tissue seem 
to revert to a more developmental phenotype may 
be gained.
 Among many possible growth, genetic and 
epigenetic factors that associate with OA incidence 
and progression, two warrant special mention; 
so-called axon guidance molecules – because they 
are normally associated with development – and 
cartilage oligomeric matrix protein (COMP) – because 
it is widely used as a serum biomarker. In preliminary 
studies, using gene arrays, an approximately 2-fold 
higher expression of spondin-1 (F-spondin) was 
found in OA bone than in osteoporotic bone and 
further exploration revealed increased expression of 
neuropilin and semaphorins (unpublished). Another 
study reports a 7-fold increase in spondin-1 in human 
OA cartilage (Attur et al., 2009). These molecules are 
traditionally studied during embryonic development 
and are associated with growth of nerves into newly 
formed tissues. Studies in embryonic cartilage suggest 
that spondin-1 has the capacity to enhance chondrocyte 
terminal differentiation and mineralisation through 
interactions in its thrombospondin-repeat domain 
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and TGF-beta dependent pathways (Palmer et al., 
2010). These studies provide supporting evidence 
for a recapitulation of developmental processes 
occurring in diseased tissues.
 Finding biomarkers for OA is a high priority, as 
evaluating radiographic joint space – which requires 
imaging – is the only current biomarker accepted by 
the US Food and Drug Administration (FDA) and 
is not a very sensitive method. COMP is identified 
as a cartilage matrix protein (DiCesare et al., 1995) 
and it was soon recognised that its degradation 
in OA could reflect disease processes occurring in 
the matrix (DiCesare et al., 1996). Elevated levels of 
COMP are found in the serum of patients with OA 
and it is proposed as a biomarker for diagnosis and 
prognosis (Verma and Dalal, 2013). Much is reported 
of attempts to elucidate its roles within cartilage 
but, for the purposes of this review, of considerable 
interest is the finding that COMP is expressed in the 
apical ectodermal ridge (AER) of the human embryo 
at gestational week 8, as well as in the cavitating joint 
at weeks 10 and 12 (Koelling et al., 2006). The AER 
is the starting point of limb formation and, hence, 
it appears to be a key player in the formation of the 
limbs. This is reinforced by another study in which 
COMP is found to be involved in the regulation 
of endochondral bone growth (Kong et al., 2010). 
Perhaps this makes it less surprising that elevated 
levels are found in OA joints, if there is a reversion 
to an earlier developmental phenotype.
Infrapatellar fat pad
The infrapatellar fat pad, located distally to 
the patella and the femur is shown to be a 
localised source of adipokines in OA as well 
as functioning as a buffering and lubricating 
tissue (Favero et al., 2017). Clockaerts et al. 
argue, in a narrative review of the area, that the 
infrapatellar fat pad should be considered to be 
an active OA tissue. This is due to the cytokines 
produced, the innervation which may be linked 
to OA pain, and the production of adipokines 
that inhibit the biosynthesis of cartilage matrix 
proteins (Clockaerts et al., 2010). In a subsequent 
paper, however, they show that conditioned 
media from the infrapatellar fat pad inhibited 
catabolic processes in the cartilage (Bastiaansen-
Jenniskens et al., 2012). Han and colleagues 
go a little further and start to speculate as to 
whether the role of fat localised to the joint area 
is a good or bad thing (Han et al., 2014). They 
show, in MRI-based studies, that there were 
several significant changes in the infrapatellar 
fat pad that had negative consequences for the 
development of OA, mainly related to volume, 
joint space narrowing and any involvement of 
bone marrow lesions. Clearly, the significant 
changes which are reported in the infrapatellar 
fat pad add to the idea of the joint being an organ. 
Another paper shows that inflamed infrapatellar 
fat pads are shown to be hyperintense on 
MRI scans of the knee. When correlated with 
structural changes, this is found to be associated 
with worsening of bone marrow lesions, a 
feature of OA pathology and more generalised 
joint damage (Jarraya et al., 2017).
Joint shape and OA
In addition to molecular events, the understanding 
of how anatomical features, such as joint shape, 
influence disease pathophysiology has evolved 
from simple gross observations. Malformation of 
a joint during development, e.g. developmental 
dysplasia of the hip, is a known risk-factor for 
later OA. However, more recently, it has been 
shown that less overt changes – often found 
associated with demanding sporting activities 
in adolescents – appear, at least in part, to 
underlie femoro-acetabular impingement – now 
recognised as a cause of later OA (reviewed by 
Pun et al., 2015). But what about more subtle 
variations in joint shape? Can these be measured 
and do any of the features identified relate to OA 
incidence or progression? It has been shown that 
the radiographic outline of the femoral head of 
patients with hip OA has a different shape from 
that of matched asymptomatic controls (Gregory 
et al., 2007) (Fig. 2). This shape can be quantified 
using Statistical Shape Modelling (SSM) (Cootes 
et al., 1995), which uses principal component 
analysis to describe the shape in terms of 
independent “modes of variation”. Each image 
in a dataset then receives a score for each mode, 
which describes how many standard deviations 
it lies from the overall mean of all the images. 
Using radiographic images from the Rotterdam 
study, none of whom were symptomatic at 
baseline, it was found that a number of modes 
were significantly associated with OA severity 
six years later and those who progressed most 
rapidly to hip replacement could be identified as 
a sub-group (Gregory et al., 2007). Subsequently, 
using SSM from DXA (dual-energy x-ray 
absorptiometry) images, it was shown that 
measures of hip shape were associated with 
radiographic hip OA, and to a lesser extent 
hip pain, in the MrOS (osteoporotic fractures 
in men) cohort (Faber et al., 2017). The method 
showed promise as an imaging biomarker, as it 
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was found that statistically significant changes 
could be measured in shape over a 12-month 
period in a small longitudinal cohort comprising 
62 individuals (Barr et al., 2018). Using data 
from the MRC National Survey of Health and 
Development (a birth cohort all born in one week 
in 1946), it was found that life-course factors 
were associated with the shape of the hip and 
spine at age 60-64 years as determined by DXA 
imaging. Being overweight, especially greater 
gains in weight during life, were associated with 
a flatter femoral head and a shorter femoral neck 
(Muthuri et al., 2017). Other epidemiological 
studies, using the same cohort, show that knee 
OA is associated with high BMI throughout 
adult life (Wills et al., 2012) and that hand OA is 
associated not only with high BMI but also with 
low birth weight, but only in men (Sayer et al., 
2003). Intriguingly, it has recently been found 
that age at first walking is associated with hip 
shape (Ireland et al., 2018) as well as with bone 
strength at the hip (Ireland et al., 2017). Using 
images from the ALSPAC (Avon Longitudinal 
Study of Parents and Children) cohort, the 
association of genes already identified as related 
to OA with hip shape modes was explored and 
several susceptibility loci were found, including 
KLHDC5-PTHLH (Kelch-like family member 
5-parathyroid-like hormone), DOT1L (DOT-1 
like methyltransferase) and COL11A1 (Collagen 
11Alpha1) (Baird et al., 2018). Combining these 
data with those from other cohorts, using a meta-
analysis, has identified 8 SNPs independently 
associated with hip shape and, curiously, many 
of them were strongly related to the process 
of endochondral bone formation (Baird et al., 
2018b). Studies of SSM in the Tasmanian Older 
Adult cohort (TASOAC), with multiple imaging 
modalities, had several modes of variation 
determined by SSM that were associated not 
only with radiographic hip OA, hip cartilage 
volume and muscle strength but also with 
pain and effusion-synovitis (Ahedi et al., 2017). 
Further analysis of these data has shown that 
hip shape as defined by SSM is also a predictor 
for the risk of total hip replacement (Mezhov et 
al., 2018).
Conclusions and clinical implications
Evidence is mounting that OA is an organ disease 
affecting the whole joint and its component tissues 
(Fig. 3). Changes in muscle, nerves and pain 
sensitivity, ligaments and the vascular system have 
all been documented and were reviewed previously 
(Aspden, 2008). The working hypothesis is that 
generalised OA affects the whole musculoskeletal 
system because it arises from renewed, dysregulated, 
growth of tissues derived largely from cells from 
the mesenchymal lineage. The particular joint or 
joints affected may then be determined by subtle 
biomechanical factors such as joint shape. Evidence 
suggests a reversion of the phenotype of their 
constituent cells to an earlier developmental stage 
that results in:
• faster turnover and hyperplasia of bone,
• increased adiposity leading to obesity,
• fibrosis of ligaments and joint capsule,
• altered muscle phenotype possibly including fat 
deposition and muscle weakness,
• proliferation of cartilage chondrocytes,
• increased matrix synthesis, but not incorporation,
all leading to weakened tissue and mechanical 
breakdown. Identifying alterations in mesenchymal 
stem cells and their niches may provide new 
insights into the proliferation of these tissues. The 
particular joints affected most may be dependent 
on local biomechanical factors and statistical shape 
modelling is beginning to suggest there may be 
subtle variations in hip shape that act throughout 
the life-course. However, the underlying disease, 
it is believed, is metabolic and systemic (Aspden et 
al., 2001). Some of these pathological changes have 
been recognised before and the Oxford surgeon Josep 
Trueta commented, “The osteoarthritic process thus 
appears to be an attempt to transform a decaying 
joint into a youthful one” (Harrison et al., 1953). After 
half a century of focussing on articular cartilage, to 
Fig. 2. Statistical shape model overlaid on 
a radiograph. The variation in shape over ±2 
standard deviations is shown (from yellow to 
red) for this mode associated with OA.
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the almost complete exclusion of other joint tissues, 
there is a returning again to the idea of OA as a joint 
disorder and a beginning to the understanding that 
processes throughout our life-course, from the cradle 
to the grave, may play a role in the pathogenesis of 
OA. A renewed focus on bone and the soft tissues 
of the joint in tandem with the cartilage will give a 
much more balanced picture of subtle changes that 
characterise OA.
 These observations have many cl inical 
implications. It becomes essential to identify OA 
in its early stages, especially those who are going 
to progress most rapidly (Gregory et al., 2007). 
Such methods and the resulting biomarkers are 
also essential for the development and effective 
testing of Disease Modifying OA drugs (DMOADs) 
in relatively short periods of time. Identifying 
circulating or urinary factors, or combinations of 
factors, deriving from tissues other than cartilage, 
such as bone, muscle or fat, may also provide new 
biomarkers of disease. Better still, a combination 
or panel of biomarkers, circulating, excretory and 
imaging, may harness better the markers we already 
know and provide a more sensitive measure of 
progression. It is believed that tissue engineering 
approaches to cartilage repair in osteoarthritis are 
almost certain not to succeed, at least in the short to 
medium term. If the natural tissue has been destroyed 
and the underlying problem has not been addressed, 
what chance is there for implanted tissue to survive, 
especially as, at least initially, the engineered tissue 
is commonly biomechanically inferior to the original? 
The exception would be local repair of damaged 
cartilage following trauma where it may be possible, 
with the correct combination of mechanical and 
biochemical cues, to engineer a tissue replacement 
that would be strong enough and could integrate 
with the existing tissue.
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